Filing Details
- Accession Number:
- 0001178913-18-000508
- Form Type:
- 13G Filing
- Publication Date:
- 2018-02-13 12:37:52
- Filed By:
- Sphera Funds Management Ltd.
- Company:
- Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
- Filing Date:
- 2018-02-13
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Moshe Arkin | 0 | 0 | 0 | 0% | ||
| Sphera Funds Management Ltd | 0 | 0 | 0 | 0% | ||
| Sphera Global Healthcare GP Ltd | 0 | 0 | 0 | 0% | ||
| Sphera Global Healthcare Management | 0 | 0 | 0 | 0% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 2)*
MARINUS PHARMACEUTICALS, INC.
(Name of Issuer)
Voting Common Stock, par value $0.001 per share
(Title of Class of Securities)
56854Q101
(CUSIP Number)
December 31, 2017
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 56854Q101 | 13G | Page 2 of 9 Pages | |||
| 1 | NAME OF REPORTING PERSONS Moshe Arkin | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☒ | ||||
| 3 | SEC USE ONLY | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION Israel | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER --- | |||
| 6 | SHARED VOTING POWER 0 | ||||
| 7 | SOLE DISPOSITIVE POWER --- | ||||
| 8 | SHARED DISPOSITIVE POWER 0 | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐ | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% | ||||
| 12 | TYPE OF REPORTING PERSON (See instructions) IN | ||||
| CUSIP No. 56854Q101 | 13G | Page 3 of 9 Pages | |||
| 1 | NAME OF REPORTING PERSONS Sphera Funds Management Ltd. | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☒ | ||||
| 3 | SEC USE ONLY | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION Israel | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER --- | |||
| 6 | SHARED VOTING POWER 0 | ||||
| 7 | SOLE DISPOSITIVE POWER --- | ||||
| 8 | SHARED DISPOSITIVE POWER 0 | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐ | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% | ||||
| 12 | TYPE OF REPORTING PERSON (See instructions) CO | ||||
| CUSIP No. 56854Q101 | 13G | Page 4 of 9 Pages | |||
| 1 | NAME OF REPORTING PERSONS Sphera Global Healthcare GP Ltd. | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☒ | ||||
| 3 | SEC USE ONLY | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION Israel | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER --- | |||
| 6 | SHARED VOTING POWER 0 | ||||
| 7 | SOLE DISPOSITIVE POWER --- | ||||
| 8 | SHARED DISPOSITIVE POWER 0 | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐ | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% | ||||
| 12 | TYPE OF REPORTING PERSON (See instructions) CO | ||||
| CUSIP No. 56854Q101 | 13G | Page 5 of 9 Pages | |||
| 1 | NAME OF REPORTING PERSONS Sphera Global Healthcare Management LP | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions) (a) ☐ (b) ☒ | ||||
| 3 | SEC USE ONLY | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION Israel | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER --- | |||
| 6 | SHARED VOTING POWER 0 | ||||
| 7 | SOLE DISPOSITIVE POWER --- | ||||
| 8 | SHARED DISPOSITIVE POWER 0 | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions) ☐ | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% | ||||
| 12 | TYPE OF REPORTING PERSON (See instructions) CO | ||||
| Item 1. (a) | Name of Issuer: |
Marinus Pharmaceuticals, Inc.
| (b) | Address of Issuer's Principal Executive Offices: |
170 N. Radnor Chester Rd, Suite 250
Radnor, PA 19087
| Item 2. (a) | Name of Person Filing: |
Moshe Arkin
Sphera Funds Management Ltd.
Sphera Global Healthcare GP Ltd.
Sphera Global Healthcare Management LP
| (b) | Address of Principal Business Office: |
Moshe Arkin – 6 Hachoshlim St., Herzelia, Israel
Sphera Funds Management Ltd. – 21 Ha'arba'ah Street, Tel Aviv 64739, Israel
Sphera Global Healthcare GP Ltd. – 21 Ha'arba'ah Street, Tel Aviv 64739, Israel
Sphera Global Healthcare Management LP – 21 Ha'arba'ah Street, Tel Aviv 64739, Israel
| (c) | Citizenship: |
Moshe Arkin – Israel
Sphera Funds Management Ltd. – Israel
Sphera Global Healthcare GP Ltd. – Israel
Sphera Global Healthcare Management LP – Israel
| (d) | Title of Class of Securities: |
Voting Common Stock, par value $0.001 per share
| (e) | CUSIP Number: |
56854Q101
| Item 3. | Not applicable. |
| Item 4. | Ownership: |
None.
| Item 5. | Ownership of Five Percent or Less of a Class: |
Moshe Arkin
Sphera Funds Management Ltd.
Sphera Global Healthcare GP Ltd.
Sphera Global Healthcare Management LP
| Item 6. | Ownership of More than Five Percent on Behalf of Another: |
Not applicable.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person: |
Not applicable.
| Item 8. | Identification and Classification of Members of the Group: |
Not applicable.
| Item 9. | Notice of Dissolution of Group: |
Not applicable.
| Item 10. | Certification: |
Not applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 12, 2018
| Moshe Arkin /s/ Moshe Arkin By: Moshe Arkin Sphera Funds Management Ltd. /s/ Ori Goldfarb By: Ori Goldfarb Title: Chief Executive Officer Sphera Global Healthcare GP Ltd. /s/ Ori Goldfarb By: Ori Goldfarb Title: Chief Executive Officer Sphera Global Healthcare Management LP /s/ Doron Breen By: Doron Breen Title: Managing Partner |
| EXHIBIT NO. | DESCRIPTION |
| Exhibit 1 | Joint Filing Agreement by and among the Reporting Persons, dated as of July 5, 2016 (incorporated herein by reference to Exhibit 1 to the Schedule 13G filed on July 6, 2016). |
9